7 results
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... Summary Mechanisms ... agent • Does not cause ... side effects (e.g ... #Summary #DM2 #
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Classes: Biguanide ... 0.3-0.6 units/kg ... Diabetes #Mellitus #DM2 ... #Inpatient #Medications ... #pharmacology #
Vasopressors and Inotropes - Pharmacology Summary
Vasopressors
Phenylephrine (alpha-1)
 • Increases BP, SVR
 • Risk of reflex bradycardia
and Inotropes - Pharmacology ... Summary Vasopressors ... • Higher doses cause ... cAMP/cGMP • Causes ... #medications
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... Summary Mechanisms ... side effects (e.g ... not definitively cause ... #Summary #DM2 #
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
anti-diabetic medications ... kidney), which causes ... the patient to ... SGLT2 #Inhibitors #Pharmacology ... #Medications #DM2
Lidocaine 5% Patch (Lidoderm) 
Medicare Covered Indications 
1. Post-herpetic neuralgia pain 
2. Diabetic peripheral neuropathy 
3.
However, if your patient ... : PHN pain, DM neuropathy ... removing the patch in case ... Patch #Lidoderm #Pharmacology ... #Indications
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Infections in HIV-AIDS Indications ... histoplasmosis (>10 cases ... /100 patient-years ... amphotericin B at 3 mg/kg ... infections #HIVAIDS #pharmacology